Abstract
Hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy (ARVD) are two important causes of sudden death in young athletes. Preparticipation screening in healthy general athlete populations may raise the suspicion of HCM or ARVD, and ultimately lead to definitive diagnosis. However, controversy has recently arisen regarding the most effective and practical strategy for the screening of athletes. European investigators have promoted routine 12-lead ECGs as part of a national mandatory program distinct from the customary practice in the US which is limited to patient history and physical examinations. Consensus criteria and recommendations for eligibility and disqualification of athletes with HCM or ARVD have proved useful to the practising community.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308–1320
Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Task Force on clinical expert society of cardiology committee for practice guidelines committee to develop an expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 42:1687–1713
Maron BJ (2009) Distinguishing hypertrophic cardiomyopathy from athletes heart physiological remodeling: clinical significance, diagnostic strategies and implications for preparticipation screening. Br J Sports Med 43:649–656
Medicina dello Sport (2010) Rivista trimestrale della Federazione Medico-Sportiva Italiana. Protocolli cardiologici per il giudizio di idoneità allo sport agonistico 2009. Marzo 2010, vol 63
Maron BJ (2007) Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification. Cardiol Clin 25:399–414
Maron BJ, Zipes DP (2005) 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45:1312–1375
Corrado D, Pelliccia A, Bjørnstad HH et al (2005) Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26:516–524
Pelliccia A, Maron BJ (1995) Preparticipation cardiovascular evaluation of the competitive athlete: Perspectives from the 30-year Italian experience. Am J Cardiol 75:827–828
Maron BJ, Thompson PD, Ackerman MJ et al (2007) Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes. 2007 Update: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation 115;1643–1655
Basso C, Corrado D, Marcus FI et al (2009) Arrhythmogenic right ventricular cardiomyopathy. Lancet 373:1289–1300
Corrado D, Thiene G, Nava A et al (1990) Sudden death in young competitive athletes: clinico-pathologic correlations in 22 cases. Am J Med 89:588–596
Corrado D, Basso C, Schiavon M et al (1998) Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339:364–369
Corrado D, Basso C, Rizzoli G et al (2003) Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42:1959–1963
McKenna WJ, Thiene G, Nava A et al. (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71:215–218
Hamid MS, Norman M, Quraishi A et al (2002) Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 40:1445–1450
Maron BJ, Pelliccia A, Spirito P (1995) Cardiac disease in young trained athletes: insights into methods for distinguishing athletès heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 91:1596–1601
Corrado D, Basso C, Pavei A et al (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296:1593–1601
Marcus FI (2005) Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyo-pathy/dysplasia. Am J Cardiol 95:1070–1071
Turrini P, Corrado D, Basso C et al (2001) Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation 103:3075–3080
Basso C, Corrado D, Thiene G et al (2007) Arrhythmogenic right ventricular cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity. Cardiol Clin 25:415–422
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Bisceglia, C., Piro, M. (2012). Cardiomyopathies in the Athlete. In: Fioranelli, M., Frajese, G. (eds) Sports Cardiology. Springer, Milano. https://doi.org/10.1007/978-88-470-2775-6_19
Download citation
DOI: https://doi.org/10.1007/978-88-470-2775-6_19
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2774-9
Online ISBN: 978-88-470-2775-6
eBook Packages: MedicineMedicine (R0)